Retinal disorder treatment market is anticipated to grow at a CAGR of 11.2% during the forecast period (2023-2030). Treating the main retinal diseases in the everlasting war against blindness and its associated morbidity has been growing steadily over the last two decades. The growing adoption of macular degeneration treatment for retinal disorder key factor supporting the growth of the market globally. Hence, the market players are also focusing on introducing macular degeneration-based retinal disorder treatment solutions that further bolster the market growth. For instance, in February 2023, Apellis Pharmaceuticals, Inc., a biopharmaceutical company in complement, announced that the US (FDA) approved SYFOVRE™ (pegcetacoplan injection) for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). SYFOVRE is the first and only FDA-approved treatment for GA, a leading cause of blindness that impacts more than one million people in the US and five million people globally.
Get Free Sample link @ https://www.omrglobal.com/request-sample/retinal-disorder-treatment-market
According to the International Agency for the Prevention of Blindness (IAPB), in 2020, China and India together accounted for 49.0% of the global total burden of blindness and vision impairment, while their populations represent 37.0% of the global population.
full report of Retinal Disorder Treatment Market available @ https://www.omrglobal.com/industry-reports/retinal-disorder-treatment-market
- Market Coverage
- Market number available for – 2023-2029
- Base year- 2022
- Forecast period- 2023-2029
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
- , and others
Global Retinal Disorder Treatment Market Report Segment
By Indication
- Diabetic Retinopathy
- Macular Degeneration
- Retinal Detachment
- Retinoblastoma
- Other (Diabetic Eye Disease, Macular Pucker, Macular Hole, Floaters)
By Dosage Form
- Gels
- Eye Solutions
- Capsules & Tablets
- Eye Drops
- Ointments
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Sales
Global Retinal Disorder Treatment Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East & Africa
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global retinal disorder treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/retinal-disorder-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
